Table 3.
The top 20 most cited works of literature on ORA.
| Title | Journal | First Author | Publication year | Total citations |
|---|---|---|---|---|
| Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis | Rheumatology | Choy E | 2012 | 420 |
| Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) | Annals of the Rheumatic Diseases | Dougados M | 2014 | 406 |
| Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis-Results from 394 patients in the Oslo County Rheumatoid Arthritis Register | Arthritis and Rheumatism | Haugeberg G | 2000 | 363 |
| Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis | Arthritis and Rheumatism | van Staa TP | 2006 | 359 |
| Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects-A randomized, double-blind, placebo-controlled clinical trial | Annals of Internal Medicine | van Everdingen AA | 2002 | 341 |
| Involvement of receptor activator of NF kappa B ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis | Bone | Romas E | 2002 | 318 |
| Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond | Frontiers in Immunology | Walsh MC | 2014 | 314 |
| RANK/RANKL: Regulators of Immune Responses and Bone Physiology | Annals of the New York Academy of Sciences | Leibbrandt A | 2008 | 280 |
| Relationship between rheumatoid arthritis and periodontitis | Journal of Periodontology | Mercado FB | 2001 | 255 |
| Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate - A two-year randomized trial | Arthritis and Rheumatism | Svensson B | 2005 | 251 |
| IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor a from T cells | Proceedings of the National Academy of Sciences of the United States of America | Toraldo G | 2003 | 209 |
| 1,25-Dihydroxyvitamin D-3 Modulates Th17 Polarization and Interleukin-22 Expression by Memory T Cells From Patients With Early Rheumatoid Arthritis | Arthritis and Rheumatism | Colin EM | 2010 | 204 |
| Osteoblast physiology in normal and pathological conditions | Cell and Tissue Research | Neve A | 2011 | 201 |
| Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies | Annals of the Rheumatic Diseases | Kleyer A | 2014 | 192 |
| Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss | Annals of the Rheumatic Diseases | Krishnamurthy A | 2016 | 184 |
| Classical and paradoxical effects of TNF-alpha on bone homeostasis | Frontiers in Immunology | Osta B | 2014 | 183 |
| Bone remodeling in rheumatic disease: a question of balance | Immunological Reviews | Walsh NC | 2010 | 166 |
| Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NF kappa B ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases | Vis M | 2006 | 164 |
| Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor | Rheumatology | Dayer JM | 2010 | 159 |
| A multicenter cross sectional study on bone mineral density in rheumatoid arthritis | Journal of Rheumatology | Sinigaglia L | 2000 | 155 |